Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rienk E Jeeninga

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
HIV Therapy|June 29, 2010
Possible applications for replicating HIV 1 vectorsAtze T Das, Rienk E Jeeninga, Ben Berkhout
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 10, 2009
The new influenza A (H1N1) pandemicRienk E Jeeninga, Menno D de Jong, Ben Berkhout
Journal of Virology|June 15, 2004
The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replicationTim van Opijnen, Joost Kamoschinski, Rienk E Jeeninga, et al.
Current Opinion in Virology|August 20, 2013
Establishment and molecular mechanisms of HIV-1 latency in T cellsRenée M van der Sluis, Rienk E Jeeninga, Ben Berkhout
Journal of Virology|February 22, 2008
Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1Jeffrey H Ringrose, Rienk E Jeeninga, Ben Berkhout, et al.
Retrovirology|September 29, 2006
Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemiasRienk E Jeeninga, Barbara Jan, Henk van den Berg, et al.
Antiviral Research|November 25, 2010
Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factorsJulia J M Eekels, Dirk Geerts, Rienk E Jeeninga, et al.
Retrovirology|April 29, 2008
HIV-1 latency in actively dividing human T cell linesRienk E Jeeninga, Ellen M Westerhout, Marja L van Gerven, et al.
Viruses|December 28, 2021
Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell LineYe Liu, Rienk E Jeeninga, Bep Klaver, et al.
Journal of Virology|February 14, 2003
Dimerization and template switching in the 5' untranslated region between various subtypes of human immunodeficiency virus type 1Ebbe Sloth Andersen, Rienk E Jeeninga, Christian Kroun Damgaard, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
HIV Therapy|June 29, 2010
Possible applications for replicating HIV 1 vectorsAtze T Das, Rienk E Jeeninga, Ben Berkhout
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 10, 2009
The new influenza A (H1N1) pandemicRienk E Jeeninga, Menno D de Jong, Ben Berkhout
Journal of Virology|June 15, 2004
The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replicationTim van Opijnen, Joost Kamoschinski, Rienk E Jeeninga, et al.
Current Opinion in Virology|August 20, 2013
Establishment and molecular mechanisms of HIV-1 latency in T cellsRenée M van der Sluis, Rienk E Jeeninga, Ben Berkhout
Journal of Virology|February 22, 2008
Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1Jeffrey H Ringrose, Rienk E Jeeninga, Ben Berkhout, et al.
Retrovirology|September 29, 2006
Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemiasRienk E Jeeninga, Barbara Jan, Henk van den Berg, et al.
Antiviral Research|November 25, 2010
Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factorsJulia J M Eekels, Dirk Geerts, Rienk E Jeeninga, et al.
Retrovirology|April 29, 2008
HIV-1 latency in actively dividing human T cell linesRienk E Jeeninga, Ellen M Westerhout, Marja L van Gerven, et al.
Viruses|December 28, 2021
Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell LineYe Liu, Rienk E Jeeninga, Bep Klaver, et al.
Journal of Virology|February 14, 2003
Dimerization and template switching in the 5' untranslated region between various subtypes of human immunodeficiency virus type 1Ebbe Sloth Andersen, Rienk E Jeeninga, Christian Kroun Damgaard, et al.
Pageof 4